Medicare Dialysis Bundle And New Drugs: Will Transitional Payments Work For Korsuva, Vadadustat?

Quick provider uptake will be key for upcoming new drugs covered by the Medicare end stage renal disease prospective payment system.

Medicare Balancing Need For Innovation With Cost Control • Source: Alamy

Medicare’s approach to reimbursing new drugs for dialysis patients in the end-stage renal disease bundled payment system may be applied to two new first-in-class drugs in 2022, and stakeholders will be watching to see how uptake among dialysis providers responds.

The Centers for Medicare and Medicaid Services provides transitional drug add-on payment adjustments (TDAPA) to innovative new drugs to help...

More from Medicare

More from Government Payers